We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 2,928 results
  1. Non-criteria autoantibodies in antiphospholipid syndrome may be associated with underlying disease activity

    Background

    Antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized by persistent antiphospholipid antibodies (aPLs) with...

    Pınar Akyüz Dağlı, Abdulsamet Erden, ... Ahmet Omma in Irish Journal of Medical Science (1971 -)
    Article 22 September 2023
  2. Rethinking antiphospholipid syndrome to guide future management and research

    Antiphospholipid syndrome (APS) consists of thrombotic, non-thrombotic and obstetric clinical manifestations develo** in individuals with...

    Jason S. Knight, Doruk Erkan in Nature Reviews Rheumatology
    Article 03 May 2024
  3. Non-criteria manifestations in primary antiphospholipid syndrome: a French multicenter retrospective cohort study

    Background

    From this retrospective study, we aimed to (1) describe the prevalence and characteristics of non-criteria features in primary...

    Alexis F. Guédon, Jennifer Catano, ... Arsène Mekinian in Arthritis Research & Therapy
    Article Open access 25 January 2022
  4. Non-criteria antiphospholipid antibodies and pediatric rheumatic disease: a case series

    Background

    Non-criteria antiphospholipid antibodies (NC-aPL) are a relatively undefined subgroup of antiphospholipid antibodies (aPL). Knowledge about...

    Shawn A. Mahmud, Danielle R. Bullock, ... Bryce A. Binstadt in Pediatric Rheumatology
    Article Open access 20 August 2022
  5. The presence of non-criteria manifestations negatively affects the prognosis of seronegative antiphospholipid syndrome patients: a multicenter study

    Background

    Seronegative antiphospholipid syndrome (SN-APS) is often defined as the presence of APS criteria manifestations, negative antiphospholipid...

    Gilberto Pires da Rosa, Bernardo Sousa-Pinto, ... Gerard Espinosa in Arthritis Research & Therapy
    Article Open access 03 January 2022
  6. Preconception Non-criteria Antiphospholipid Antibodies and Risk of Subsequent Early Pregnancy Loss: a Retrospective Study

    The aim of this study was to investigate the subsequent early pregnancy outcomes in women positive for non-criteria antiphospholipid antibodies...

    Fangxiang Mu, Mei Wang, ... Fang Wang in Reproductive Sciences
    Article Open access 06 November 2023
  7. Thrombotic microangiopathy due to primary antiphospholipid syndrome: successful treatment with eculizumab

    Antiphospholipid syndrome nephropathy includes a variety of histological lesions, including thrombotic microangiopathy, which is not included among...

    Chiara Pala, Elisabetta Parenti, ... Giovanni Maria Rossi in Journal of Nephrology
    Article 17 October 2023
  8. Antiphospholipid Syndrome: State of the Art of Clinical Management

    Antiphospholipid syndrome (APS) is a systemic autoimmune disorder clinically characterized by recurrent arterial and venous thrombosis and/or...

    Luca Depietri, Maria Rosaria Veropalumbo, ... Angelo Ghirarduzzi in Cardiovascular Drugs and Therapy
    Article 12 August 2023
  9. Antiphospholipid syndrome, thrombosis, and vaccination in the COVID-19 pandemic

    Thrombosis is one of the many signs of antiphospholipid syndrome (APS) and COVID-19 infection. Although the mechanisms contributing to thrombosis in...

    Tatjana Zekić, Andrej Belančić in Rheumatology International
    Article 23 February 2024
  10. Serum Calprotectin as a Potential Predictor of Microvascular Manifestations in Patients with Antiphospholipid Syndrome

    Introduction

    Microvascular manifestations constitute a subtype of antiphospholipid syndrome, and those patients have relatively poor prognoses, so it...

    Yuan Zhao, Wanting Qi, ... Jiuliang Zhao in Rheumatology and Therapy
    Article Open access 31 October 2023
  11. Cutaneous microvascular occlusion syndrome as the first manifestation of catastrophic lupus-associated antiphospholipid antibody syndrome: a case report

    Background

    Antiphospholipid syndrome (APS), defined by thrombotic events or obstetric complications in the presence of persistently high...

    Nastaran-Sadat Hosseini, Sharareh Babaei, ... Bahareh Abtahi-Naeini in Journal of Medical Case Reports
    Article Open access 22 August 2023
  12. Choice of anticoagulation in patients with low risk antiphospholipid syndrome

    Antiphospholipid syndrome (APS) is an acquired hypercoagulable state necessitating long-term anticoagulation for secondary thrombosis prevention....

    Brianna R. Bakow, Quan Phung, ... John L Reagan in Journal of Thrombosis and Thrombolysis
    Article 23 May 2023
  13. Neurologic Manifestations of Catastrophic Antiphospholipid Syndrome

    Purpose of Review

    Understanding of antiphospholipid antibody syndrome (APS), associated neurological manifestations, and disease-directed treatment...

    Article 30 August 2022
  14. A case of repeated in-stent restenosis of coronary artery as a primary manifestation of seronegative antiphospholipid antibody syndrome

    Background

    Antiphospholipid antibody syndrome (APS) is a multisystemic autoimmune disorder which affects many organs or systems; however, coronary...

    Mingqiang Fu, Shufu Chang, ... Junbo Ge in BMC Cardiovascular Disorders
    Article Open access 06 January 2024
  15. Spontaneous coronary artery dissection in a young patient with antiphospholipid syndrome

    A 28-year-old man diagnosed with triple positive antiphospholipid syndrome (APS) and undergoing warfarin experienced three separate admissions to the...

    Ai Phi Thuy Ho, Eirik Tjønnfjord, ... Ellen Elisabeth Brodin in Thrombosis Journal
    Article Open access 17 January 2024
  16. Loss of opportunities in the diagnosis and treatment of primary obstetric antiphospholipid syndrome (POAPS): from theory to reality

    Objectives

    (I) To identify and measure the clinical consequences of a delayed diagnosis in patients with primary obstetric antiphospholipid syndrome...

    Sebastián Udry, José O. Latino, ... Gabriela de Larrañaga in Clinical Rheumatology
    Article 04 March 2024
  17. Pregnancy and Clinical Outcome Among Women with Antiphospholipid Antibody Syndrome—A Tertiary Care Center–Based Observational Study

    Antiphospholipid antibody syndrome (APS) is an acquired thrombophilia with multisystem involvement. This study was undertaken to study the antibody...

    Yavana Suriya Venkatesh, Murali Subbaiah, ... Rajeswari Murugesan in SN Comprehensive Clinical Medicine
    Article 19 January 2024
  18. An Update on Antiphospholipid Syndrome

    Purpose of Review

    To review the recent available evidence on epidemiology, pathogenesis, clinical phenotypes, and management of antiphospholipid...

    Eleni Xourgia, Maria G. Tektonidou in Current Rheumatology Reports
    Article 01 December 2021
  19. Insight into antiphospholipid syndrome: the role and clinical utility of neutrophils extracellular traps formation

    Antiphospholipid syndrome (APLS) is a systemic immune dysregulation distinguished by repetitive complications and pregnancy loss in the absence of...

    Shams ElDoha Galal ElDin Zaiema, Menna Allah Zakaria Mohammad Ali Abou Elwafa, ... Raghda El Sayed Abdel Monem Galal in Thrombosis Journal
    Article Open access 28 March 2024
  20. Primary antiphospholipid syndrome in pediatrics: beyond thrombosis. Report of 32 cases and review of the evidence

    Objective

    Describe the frequency of thrombotic and non-thrombotic clinical manifestations, laboratory, treatment and prognosis in patients with...

    Alfonso-Ragnar Torres-Jimenez, Virginia Ramirez-Nova, ... Francisco Xavier Guerra-Castillo in Pediatric Rheumatology
    Article Open access 14 February 2022
Did you find what you were looking for? Share feedback.